title: [The Pharmacist as Gatekeeper of Prescription Drug Abuse: Return to "Community Scientists"].
abstract: The non-medical use or abuse of prescription drugs, including benzodiazepines, is a growing health problem in Japan. An association between prescription drug overdose and suicide risk has also been reported. The Japanese Ministry of Health, Labour and Welfare has expected pharmacists to act as "gatekeepers", facilitating early identification of individuals at high risk of prescription drug abuse including overdose, supplying medication counseling to patients, and helping to introduce these patients to appropriate medical care. Prescription drugs such as benzodiazepines are widely used in psychiatry. However, these drugs are prescribed not only by psychiatrists but also by other healthcare professionals including primary care physicians. Moreover, in recent years, the dispensing of prescriptions has moved rapidly from inside to outside hospitals, with prescription drugs being dispensed mainly at community pharmacies. Although all healthcare professionals including hospital pharmacists can play a role in preventing prescription drug abuse, the role of the community pharmacist is vital in addressing this problem. Formerly, community pharmacists were recognized as "community scientists", low-threshold accessible healthcare advisors. Now, community pharmacists should return to the role of community scientists to prevent prescription drug abuse. This article begins by reviewing the current situation of prescription drug abuse and dependence in Japan. The role of pharmacists as gatekeepers in preventing prescription drug abuse is then examined. Finally, this article discusses the effect of intervention in the form of gatekeeper training for community pharmacists.
authors.affiliation: Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry.
authors.forename: Takuya
authors.initials: T
authors.lastname: Shimane
mesh_terms: D001569:Benzodiazepines / Q000009:adverse effects; D003157:Community Pharmacy Services / Q000639:trends; D003376:Counseling; D062787:Drug Overdose / Q000517:prevention & control; D006801:Humans; D007564:Japan; D010595:Pharmacists; D063487:Prescription Drug Misuse / Q000517:prevention & control*; D024382:Professional Role; D012306:Risk; D000092864:Suicide Prevention
chemical_list: D001569:Benzodiazepines